Critical Signaling Hubs:
1. EGFR: Primary receptor tyrosine kinase
2. RAS: Central signal transducer
3. ERK1: Main effector kinase
4. AKT1: Survival pathway integrator
5. PI3K: Lipid kinase signaling initiator

Therapeutic Implications:
- EGFR inhibitors (gefitinib, erlotinib)
- MEK inhibitors (trametinib)
- AKT inhibitors in development
- PI3K pathway targeted therapies
